Drugs / Alfa-tocopherol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT01113671 | Jan 2009 → Jul 2010 | type 2 diabetes mellitus | Technion, Israel Institute of Technology | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02251041 Comparator | Sep 2014 → Feb 2019 | — | Universitaire Ziekenhuizen KU Leuven | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alfa-tocopherol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02251041 ↗ |
| Known as | d-alpha-tocopheryl acetate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01113671 ↗ |
| Route | Oral | “administered P.O. as soft gel capsules.” NCT01113671 ↗ |